Quick finger prick could soon make Alzheimer’s testing much more accessible

A quick finger prick and a few drops of blood on a card that can be sent in regular mail. This approach could soon make Alzheimer’s testing much more accessible worldwide.

Herpes Labialis (Oral Herpes) drugs in development, 2023 – Pharmaceutical Technology

Share this article The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides

December 1, 2023

Ribociclib succinate by Novartis for Pediatric Diffuse Intrinsic Pontine Glioma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

May 17, 2024

In a world first, Vertex, CRISPR win UK approval for CRISPR-edited therapy to treat sickle cell disease, beta-thalassemia

Vertex and CRISPR Therapeutics have won the first-ever approval for a therapy created with CRISPR gene editing, as the UK drug regulator MHRA greenlights their

November 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.